Which has better valuation and earnings, ONMDW or ACONW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OneMedNet $1.46M N/A N/A N/A N/A Aclarion $83.77K N/A N/A N/A N/A

Is ONMDW or ACONW more profitable?

Company Net Margins Return on Equity Return on Assets OneMedNet N/A N/A N/A Aclarion N/A N/A N/A

Which has preferable earnings and valuation, VSEEW or ACONW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio VSee Health $14.46M N/A N/A N/A N/A Aclarion $83.77K N/A N/A N/A N/A

Is VSEEW or ACONW more profitable?

Company Net Margins Return on Equity Return on Assets VSee Health N/A N/A N/A Aclarion N/A N/A N/A

Do analysts recommend VEEV or ACONW?

Veeva Systems presently has a consensus price target of $284.88, indicating a potential downside of 4.14%. Given Veeva Systems' stronger consensus rating and higher possible upside, research analysts plainly believe Veeva Systems is more favorable than Aclarion. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veeva Systems 1 Sell rating(s) 8 Hold rating(s) 19 Buy rating(s) 0 Strong Buy rating(s) 2.64 Aclarion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, VEEV or ACONW?

Veeva Systems has higher revenue and earnings than Aclarion. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Veeva Systems $3.20B 15.06 $908.91M $6.08 48.88 Aclarion $83.77K N/A N/A N/A N/A

Do analysts recommend ACONW or DOCS?

Doximity has a consensus target price of $31.95, indicating a potential upside of 6.61%. Given Doximity's stronger consensus rating and higher probable upside, analysts plainly believe Doximity is more favorable than Aclarion. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Doximity 3 Sell rating(s) 14 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.24

Which has higher valuation & earnings, ACONW or DOCS?

Doximity has higher revenue and earnings than Aclarion. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aclarion $83.77K N/A N/A N/A N/A Doximity $644.86M 8.29 $196.05M $0.85 35.26

Is ACONW or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Aclarion's net margin of 0.00%. Doximity's return on equity of 18.06% beat Aclarion's return on equity. Company Net Margins Return on Equity Return on Assets Aclarion N/A N/A N/A Doximity 25.48% 18.06% 15.40%

Do analysts recommend WAY or ACONW?

Waystar currently has a consensus price target of $34.67, suggesting a potential upside of 29.02%. Given Waystar's stronger consensus rating and higher possible upside, equities analysts plainly believe Waystar is more favorable than Aclarion. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Waystar 0 Sell rating(s) 4 Hold rating(s) 18 Buy rating(s) 2 Strong Buy rating(s) 2.92 Aclarion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation and earnings, WAY or ACONW?

Waystar has higher revenue and earnings than Aclarion. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.69 $112.09M $0.70 38.39 Aclarion $83.77K N/A N/A N/A N/A

Is WAY or ACONW more profitable?

Waystar has a net margin of 11.18% compared to Aclarion's net margin of 0.00%. Waystar's return on equity of 7.03% beat Aclarion's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% Aclarion N/A N/A N/A

Aclarion (ACONW) Competitors

$0.03 +0.01 (+32.23%)

Closing price 10/14/2026 03:57 PM Eastern

Extended Trading

$0.03 +0.00 (+3.23%)

As of 10/14/2026 04:03 PM Eastern

Compare

ACONW vs. ONMDW, VSEEW, VEEV, DOCS, and WAY

Should you buy Aclarion stock or one of its competitors? Aclarion's main competitors and comparable companies include OneMedNet (ONMDW), VSee Health (VSEEW), Veeva Systems (VEEV), Doximity (DOCS), and Waystar (WAY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Aclarion compare to OneMedNet?

OneMedNet (NASDAQ:ONMDW) and Aclarion (NASDAQ:ACONW) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership.

In the previous week, OneMedNet and OneMedNet both had 1 articles in the media. OneMedNet's average media sentiment score of 1.82 beat Aclarion's score of 1.21 indicating that OneMedNet is being referred to more favorably in the media.

Company	Overall Sentiment
OneMedNet	Very Positive
Aclarion	Positive

Company	Net Margins	Return on Equity	Return on Assets
OneMedNet	N/A	N/A	N/A
Aclarion	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OneMedNet	$1.46M	N/A	N/A	N/A	N/A
Aclarion	$83.77K	N/A	N/A	N/A	N/A

Summary

OneMedNet beats Aclarion on 2 of the 2 factors compared between the two stocks.

How does Aclarion compare to VSee Health?

VSee Health (NASDAQ:VSEEW) and Aclarion (NASDAQ:ACONW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

In the previous week, Aclarion had 1 more articles in the media than VSee Health. MarketBeat recorded 1 mentions for Aclarion and 0 mentions for VSee Health. Aclarion's average media sentiment score of 1.21 beat VSee Health's score of 0.00 indicating that Aclarion is being referred to more favorably in the news media.

Company	Overall Sentiment
VSee Health	Neutral
Aclarion	Positive

Company	Net Margins	Return on Equity	Return on Assets
VSee Health	N/A	N/A	N/A
Aclarion	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VSee Health	$14.46M	N/A	N/A	N/A	N/A
Aclarion	$83.77K	N/A	N/A	N/A	N/A

Summary

Aclarion beats VSee Health on 2 of the 3 factors compared between the two stocks.

How does Aclarion compare to Veeva Systems?

Veeva Systems (NYSE:VEEV) and Aclarion (NASDAQ:ACONW) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

Veeva Systems has a net margin of 29.34% compared to Aclarion's net margin of 0.00%. Veeva Systems' return on equity of 14.25% beat Aclarion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veeva Systems	29.34%	14.25%	11.71%
Aclarion	N/A	N/A	N/A

Veeva Systems has higher revenue and earnings than Aclarion.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veeva Systems	$3.20B	15.06	$908.91M	$6.08	48.88
Aclarion	$83.77K	N/A	N/A	N/A	N/A

Veeva Systems presently has a consensus price target of $284.88, indicating a potential downside of 4.14%. Given Veeva Systems' stronger consensus rating and higher possible upside, research analysts plainly believe Veeva Systems is more favorable than Aclarion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veeva Systems	1 Sell rating(s)	8 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.64
Aclarion	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

88.2% of Veeva Systems shares are owned by institutional investors. 10.6% of Veeva Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Veeva Systems had 35 more articles in the media than Aclarion. MarketBeat recorded 36 mentions for Veeva Systems and 1 mentions for Aclarion. Aclarion's average media sentiment score of 1.21 beat Veeva Systems' score of 0.48 indicating that Aclarion is being referred to more favorably in the news media.

Company	Overall Sentiment
Veeva Systems	Neutral
Aclarion	Positive

Summary

Veeva Systems beats Aclarion on 10 of the 11 factors compared between the two stocks.

How does Aclarion compare to Doximity?

Aclarion (NASDAQ:ACONW) and Doximity (NYSE:DOCS) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

Doximity has higher revenue and earnings than Aclarion.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$83.77K	N/A	N/A	N/A	N/A
Doximity	$644.86M	8.29	$196.05M	$0.85	35.26

In the previous week, Doximity had 23 more articles in the media than Aclarion. MarketBeat recorded 24 mentions for Doximity and 1 mentions for Aclarion. Aclarion's average media sentiment score of 1.21 beat Doximity's score of 0.13 indicating that Aclarion is being referred to more favorably in the media.

Company	Overall Sentiment
Aclarion	Positive
Doximity	Neutral

Doximity has a consensus target price of $31.95, indicating a potential upside of 6.61%. Given Doximity's stronger consensus rating and higher probable upside, analysts plainly believe Doximity is more favorable than Aclarion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Doximity	3 Sell rating(s)	14 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.24

Doximity has a net margin of 25.48% compared to Aclarion's net margin of 0.00%. Doximity's return on equity of 18.06% beat Aclarion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	N/A	N/A	N/A
Doximity	25.48%	18.06%	15.40%

87.2% of Doximity shares are held by institutional investors. 31.8% of Doximity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Doximity beats Aclarion on 11 of the 12 factors compared between the two stocks.

How does Aclarion compare to Waystar?

Waystar (NASDAQ:WAY) and Aclarion (NASDAQ:ACONW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

In the previous week, Waystar had 3 more articles in the media than Aclarion. MarketBeat recorded 4 mentions for Waystar and 1 mentions for Aclarion. Aclarion's average media sentiment score of 1.21 beat Waystar's score of 0.71 indicating that Aclarion is being referred to more favorably in the news media.

Company	Overall Sentiment
Waystar	Positive
Aclarion	Positive

Waystar has a net margin of 11.18% compared to Aclarion's net margin of 0.00%. Waystar's return on equity of 7.03% beat Aclarion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Aclarion	N/A	N/A	N/A

Waystar has higher revenue and earnings than Aclarion.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.69	$112.09M	$0.70	38.39
Aclarion	$83.77K	N/A	N/A	N/A	N/A

Waystar currently has a consensus price target of $34.67, suggesting a potential upside of 29.02%. Given Waystar's stronger consensus rating and higher possible upside, equities analysts plainly believe Waystar is more favorable than Aclarion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.92
Aclarion	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Waystar beats Aclarion on 9 of the 10 factors compared between the two stocks.

Get Aclarion News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACONW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACONW vs. The Competition

Export

Metric	Aclarion	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$1.90B	$7.18B	$13.18B
Dividend Yield	N/A	3.94%	2.52%	19.59%
P/E Ratio	N/A	19.05	216.61	19.63
Price / Sales	N/A	91.81	565.61	77.64
Price / Cash	N/A	32.17	76.68	52.75
Price / Book	N/A	5.88	10.37	5.92
Net Income	N/A	-$19.09M	$3.50B	$380.90M
7 Day Performance	N/A	-1.09%	-3.51%	-3.90%
1 Month Performance	N/A	-2.45%	-7.78%	-6.42%
1 Year Performance	N/A	-21.65%	0.86%	-6.01%

Aclarion Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACONW Aclarion	N/A	$0.03 +32.2%	N/A	-51.1%	$0.00	$83.77K	N/A	11
ONMDW OneMedNet	N/A	$0.03 -13.5%	N/A	N/A	$0.00	$1.46M	N/A	23	Gap Down
VSEEW VSee Health	N/A	$0.02 flat	N/A	N/A	$0.00	$14.46M	N/A	N/A
VEEV Veeva Systems	2.8507 of 5 stars	$283.33 +3.7%	$284.88 +0.5%	+3.3%	$45.87B	$3.20B	46.60	7,928	Trending News
DOCS Doximity	3.895 of 5 stars	$28.69 +2.7%	$31.95 +11.4%	N/A	$5.11B	$644.86M	33.75	880	Trending News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ACONW) was last updated on 10/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aclarion (ACONW) Competitors